Zucca et al reported prognostic factors for males with primary diffuse large cell non-Hodgkin's malignant lymphoma arising in a testis. Patients with diffuse large cell lymphoma of the testis tend to have worse outcomes than diffuse large cell lymphoma arising in other extranodal sites, with a significant rate of CNS relapse. The authors are from the International Extranodal Lymphoma Study Group (IELSG).
Parameters:
(1) International Prognostic Index (IPI, see above in 28.07.04)
(2) B symptoms (see above)
(3) chemotherapy type
(4) prophylactic radiotherapy
(5) CNS prophylaxis
B-type symptoms: one or more of the following
(1) unexplained, recurrent or sustained fever, with temperature > 38°C
(2) drenching night sweats
(3) weight loss > 10% over the 6 months prior to diagnosis
Parameters |
Finding |
Points |
International Prognostic Index |
low (score 0-1) |
1 |
|
low-intermediate (score 2) |
1 |
|
intermediate-high (score 3) |
0 |
|
high (score 4-5) |
0 |
B symptoms |
none |
1 |
|
>= 1 |
0 |
chemotherapy |
anthracycline included |
1 |
|
no anthracycline used |
0 |
prophylactic radiotherapy to contralateral testis |
given |
1 |
|
not given |
0 |
CNS prophylaxis |
given |
1 |
|
not given |
0 |
number of favorable prognostic factors =
= SUM (points for all 5 parameters)
Interpretation:
• minimum number of favorable prognostic factors: 0
• maximum number of favorable prognostic factors: 5
• Long term survival was greatest in patients with all 5 favorable prognostic factors.
• Patients who did not receive prophylactic testicular radiation were at risk for disease occurring in the contralateral testis.
• Patients who did not receive CNS prophylaxis were at risk for CNS relapse.
Specialty: Hematology Oncology
ICD-10: ,